Endocannabinoid-mediated control of synaptic transmission - PubMed (original) (raw)
Review
Endocannabinoid-mediated control of synaptic transmission
Masanobu Kano et al. Physiol Rev. 2009 Jan.
Free article
Abstract
The discovery of cannabinoid receptors and subsequent identification of their endogenous ligands (endocannabinoids) in early 1990s have greatly accelerated research on cannabinoid actions in the brain. Then, the discovery in 2001 that endocannabinoids mediate retrograde synaptic signaling has opened up a new era for cannabinoid research and also established a new concept how diffusible messengers modulate synaptic efficacy and neural activity. The last 7 years have witnessed remarkable advances in our understanding of the endocannabinoid system. It is now well accepted that endocannabinoids are released from postsynaptic neurons, activate presynaptic cannabinoid CB(1) receptors, and cause transient and long-lasting reduction of neurotransmitter release. In this review, we aim to integrate our current understanding of functions of the endocannabinoid system, especially focusing on the control of synaptic transmission in the brain. We summarize recent electrophysiological studies carried out on synapses of various brain regions and discuss how synaptic transmission is regulated by endocannabinoid signaling. Then we refer to recent anatomical studies on subcellular distribution of the molecules involved in endocannabinoid signaling and discuss how these signaling molecules are arranged around synapses. In addition, we make a brief overview of studies on cannabinoid receptors and their intracellular signaling, biochemical studies on endocannabinoid metabolism, and behavioral studies on the roles of the endocannabinoid system in various aspects of neural functions.
Similar articles
- Endocannabinoids and retrograde modulation of synaptic transmission.
Ohno-Shosaku T, Tanimura A, Hashimotodani Y, Kano M. Ohno-Shosaku T, et al. Neuroscientist. 2012 Apr;18(2):119-32. doi: 10.1177/1073858410397377. Epub 2011 Apr 29. Neuroscientist. 2012. PMID: 21531987 Review. - Endocannabinoids and synaptic function in the CNS.
Hashimotodani Y, Ohno-Shosaku T, Kano M. Hashimotodani Y, et al. Neuroscientist. 2007 Apr;13(2):127-37. doi: 10.1177/1073858406296716. Neuroscientist. 2007. PMID: 17404373 Review. - [Lipid mediator endocannabinoids in modulating synaptic transmission].
Hashimotodani Y, Tanimura A, Kano M. Hashimotodani Y, et al. Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Jun;31(3):105-9. Nihon Shinkei Seishin Yakurigaku Zasshi. 2011. PMID: 21800700 Review. Japanese. - Calcium signaling and synaptic modulation: regulation of endocannabinoid-mediated synaptic modulation by calcium.
Ohno-Shosaku T, Hashimotodani Y, Maejima T, Kano M. Ohno-Shosaku T, et al. Cell Calcium. 2005 Sep-Oct;38(3-4):369-74. doi: 10.1016/j.ceca.2005.06.014. Cell Calcium. 2005. PMID: 16085309 Review. - Role of endogenous cannabinoids in synaptic signaling.
Freund TF, Katona I, Piomelli D. Freund TF, et al. Physiol Rev. 2003 Jul;83(3):1017-66. doi: 10.1152/physrev.00004.2003. Physiol Rev. 2003. PMID: 12843414 Review.
Cited by
- Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system.
Hoffman AF, Lupica CR. Hoffman AF, et al. Cold Spring Harb Perspect Med. 2013 Aug 1;3(8):a012237. doi: 10.1101/cshperspect.a012237. Cold Spring Harb Perspect Med. 2013. PMID: 23209160 Free PMC article. Review. - Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation.
Gremel CM, Chancey JH, Atwood BK, Luo G, Neve R, Ramakrishnan C, Deisseroth K, Lovinger DM, Costa RM. Gremel CM, et al. Neuron. 2016 Jun 15;90(6):1312-1324. doi: 10.1016/j.neuron.2016.04.043. Epub 2016 May 26. Neuron. 2016. PMID: 27238866 Free PMC article. - Diacylglycerol lipaseα (DAGLα) and DAGLβ cooperatively regulate the production of 2-arachidonoyl glycerol in autaptic hippocampal neurons.
Jain T, Wager-Miller J, Mackie K, Straiker A. Jain T, et al. Mol Pharmacol. 2013 Aug;84(2):296-302. doi: 10.1124/mol.113.085217. Epub 2013 Jun 7. Mol Pharmacol. 2013. PMID: 23748223 Free PMC article. - Cannabinoid receptor signaling and modulation of monoamines: implications for psychiatric and neurological disorders.
Van Bockstaele EJ. Van Bockstaele EJ. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jul 2;38(1):1-3. doi: 10.1016/j.pnpbp.2012.01.002. Epub 2012 Jan 10. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 22251566 Free PMC article. No abstract available. - State of the art treatments for cannabis dependence.
Danovitch I, Gorelick DA. Danovitch I, et al. Psychiatr Clin North Am. 2012 Jun;35(2):309-26. doi: 10.1016/j.psc.2012.03.003. Epub 2012 Apr 10. Psychiatr Clin North Am. 2012. PMID: 22640758 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources